SCHEMBL5265348

SCHEMBL5265348

COc1ccc(-c2nc3nc(C)ccn3c2-c2ccc(SC)c(Cl)c2)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.38
AKT2 P31751 2/20 0.38
MAPK14 Q16539 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALOX15 P16050 1/20 0.35
NPC1 O15118 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
GRM2 Q14416 2/20 0.34
PTGS2 P35354 3/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DPP4 P27487 1/20 0.34
RAB9A P51151 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5261629 0.92 ALDH1A1 (0.46) AKT1AKT2MAPK14ALDH1A1HTT
SCHEMBL5260224 0.88 AKT1 (0.41) AKT1AKT2MAPK14ALDH1A1HTT
SCHEMBL5261621 0.88 AKT1 (0.41) AKT1AKT2MAPK14ALDH1A1HTT
SCHEMBL5263328 0.86 SYK (0.42) AKT1AKT2MAPK14ALDH1A1ALOX15
SCHEMBL5263026 0.85 AKT1 (0.43) AKT1AKT2MAPK14ALDH1A1NPC1
SCHEMBL5262720 0.85 TUBB4A (0.43) AKT1AKT2ALDH1A1NPC1ADORA2A
SCHEMBL5261962 0.84 AKT1 (0.43) AKT1AKT2MAPK14ALDH1A1PTGS2
SCHEMBL5263373 0.84 MAPK14 (0.51) AKT1AKT2MAPK14PTGS2PTGS1
SCHEMBL5263776 0.83 HSP90AA1 (0.41) AKT1AKT2MAPK14ALDH1A1ALOX15
SCHEMBL5262639 0.82 AKT1 (0.36) AKT1AKT2MAPK14ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660500-B1 SUBSTITUTED IMIDAZOPYRIMIDINES FOR THE PREVENTION AND TREATMENT OF CANCER S A L V A T LAB SA (ES) 2007-12-12 EP disclosed